AntonioAnzuetoMD

Critical Care Medicine

Professor, Medicine, University of Texas Medical School, San Antonio

Dr. Anzueto is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
7703 Floyd Curl Dr
# MC7977
San Antonio, TX 78229
Phone+1 210-257-1400

Fax+1 210-257-1428

University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Pulmonary Disease and Critical Care Medicine, 1989 - 1992
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Internal Medicine, 1987 - 1988
Universidad de San Carlos FOMSClass of 1979

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

PubMed

GOLD Science Committee recommendations for the use of pre- and post-bronchodilator spirometry for the diagnosis of COPD.
Dave Singh, Robert Stockley, Antonio Anzueto, Alvar Agusti, Jean Bourbeau
The European Respiratory Journal. 2024-12-05
The emerging role of alarmin-targeting biologics in the treatment of patients with COPD.
Bartolome R Celli, Antonio Anzueto, Dave Singh, Nicola A Hanania, Leonardo Fabbri
Chest. 2024-12-02
Effectiveness of Single Versus Multiple Inhaler Triple Therapy on Mortality and Cardiopulmonary Risk Reduction in COPD: The SKOPOS-MAZI Study.
Michael Pollack, Eleni Rapsomaniki, Antonio Anzueto, Kirsty Rhodes, Nathaniel M Hawkins
The American Journal of Medicine. 2024-11-18

Dual Phosphodiesterase Inhibitor Improved Lung Function in COPD PatientsMay 24th, 2023
Verona Pharma to Present Expanded Analyses of Positive Phase 3 ENHANCE Studies in COPD in Multiple Presentations at ATS 2023May 2nd, 2023
Boehringer Ingelheim Welcomes New 2023 GOLD Report Positioning LAMA/LABA as the Preferred Treatment for the Majority of Patients with COPDNovember 17th, 2022
Join now to see all